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  Mus Musculus was randomly mutagenized using N-ethyl-N-nitrosourea (ENU).  
Mutations on Chromosome 5 were selected using the Rw inversion, a visibly marked, 
recessive, lethal inversion that covers almost fifty megabases (Mb).   Multiple mutations 
were isolated from the subsequent three-generation mutagenesis screen, one of which was 
lethal 6.  Using a combination of complementation tests and recombinational mapping, the 
lethal 6 region was narrowed down to less than 1.4 (Mb).  There were thirty-eight candidate 
genes in this region of which 4 had already been mutated and yielded viable progeny.  The 
coding regions of 80% of the remaining thirty-four genes have been ruled out from being 
lethal 6, although it is still possible that ENU affected the regulation of one of these genes.  
Mice homozygous for lethal 6 die around E8.0 and preliminary results from blastocyst 
outgrowth assays suggest that they are unable to implant. 
 
Introduction: 
 
The process of early mammalian development is remarkably similar between 
different species. Embryogenesis follows the same patterns, and the basic processes are 
controlled by the same conserved genes in different organisms.  To discover the genes 
necessary for normal human development, the organism Mus musculus is a good model 
because approximately 93% of mouse loci are found in the same position in both mice and 
humans (Mouse Genome Sequencing Consortium, 2002).  Mus musculus is also a good 
model organism because they have a short gestation period, big litter sizes, and short life 
cycles. Genes that are necessary for embryonic development of Mus musculus will most 
likely be necessary for the embryonic development of humans.   The genes required for 
embryonic development of Mus musculus should have very similar sequences and 
  2chromosomal locations when compared with genes necessary for the embryonic development 
of Homo sapiens.  
The work of the Human Genome Project has led to the sequencing of both the mouse 
and human genomes.  This project has also led to the identification of many expressed genes 
whose sequence, location, and expression patterns are known.  These genes are documented 
in numerous databases, including UCSC Genome Browser and Ensembl.   
While the locations of these genes are known, most of the genes’ functions are not 
known.  In order to figure this out, the genome is mutated and scanned for any novel 
phenotypes.  After narrowing down the possible region of the gene causing the novel 
phenotype, the gene can be matched with known expressed genes found on the above 
databases through sequencing.  Direct experimentation is necessary to determine the gene 
function, and Mus musculus should be used as a model organism to alleviate ethical and 
medical concerns. This type of experimentation, called forward genetics, involves randomly 
mutagenizing the genome and identifying and isolating any genes that cause phenotypic 
abnormalities.   
In this experiment, the genome was mutagenized with the chemical N-ethyl-N-
nitrosourea (ENU).  ENU affects the male germ line by inducing point mutations at a high 
frequency.  Mutations within the region spanned by Rw, a visibly marked, lethal, recessive 
inversion that spans almost fifty megabases (Mb) on the 5
th chromosome of Mus musculus, 
were recovered.  The Rw inversion causes heterozygotes to be partially depigmented and 
homozygotes to die during embryogenesis, around age E9.5 (Bucan et al. 1995). Since the 
inversion suppresses recombination, Rw is useful as a balancer chromosome and was used in 
a three-generation mutagenesis screen.  A balancer chromosome is used to ensure that there 
  3is no crossing over between chromosomes, and therefore the original chromosomes (i.e. Rw, 
B6*) remain the same.  Because the genotype of the progeny is quickly detectable due to the 
depigmentation caused by Rw, breeding schemes are easier and more effective than if Rw 
was not used.   
This mutagenesis screen yielded thirty-seven mutations that caused embryonic or 
perinatal lethality (Wilson et al. 2005).  Of these, I have been working on a mutation called 
L5Jcs6, or lethal 6.   When this gene is mutated and homozygous, it causes embryonic 
lethality in Mus musculus.   Lethal 6 is therefore known as an embryonic recessive lethal 
gene mutation.  Subsequently, I explain the results of the experiment: the location and 
sequencing of the lethal 6 gene and the time that the developing embryo dies from the effects 
of the mutation. 
 
Results: 
 
Isolating the Lethal 6 mutation: 
 
 After  randomly  mutagenizing  the  genome of chromosome 5 of a C57BL/6 (B6) 
mouse with the ENU mutagen, the mutations were isolated in the following way.  After the 
mutagenesis, the offspring were mated to a female that had the genotype C3H/Rw.  These 
genotypes refer to C3H – a strain of mice that has a slightly different genotype than B6 mice 
do.  Rw is an inversion that arose on a C3H strain.  This inversion is a visibly marked 
recessive lethal inversion spanning almost fifty megabases (Mb), from around 26 Mb to 74 
Mb.  The offspring that were B6/Rw were identified by the depigmentation of their 
abdomens, and mated with Rw/Hm.  Hm (Hammertoe) is another visibly marked mutation, 
resulting in webbed digits.  Progeny that had the Rw phenotype but not the Hm phenotype 
were then intercrossed (Wilson et al. 2005). The progeny of this cross could theoretically 
  4yield three possible genotypes: B6/Rw, Rw/Rw, or B6/B6.  Since Rw/Rw animals die during 
development, only B6/Rw animals or B6/B6 should survive if there was no mutation.  
Embryonic lethal mutations were identified when this last cross yielded no animals that were 
B6/B6 (Figure 1).  In this way, almost forty mutations were previously discovered.  I have 
been working on one of these, L5Jcs6, or lethal 6. 
  
Figure 1:  Three-Generation Mutagenesis Breeding Scheme:  Mutated B6 mice were isolated 
by mating them with a combination of visibly marked mutations.  Since Rw suppresses 
recombination, the only the mice with abdomen depigmentation could contain the B6* 
chromosome. 
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Mapping the Lethal 6 mutation: 
 
 
  To narrow down the region, complementation tests were done between lethal 6 and 
three deletions in the Rw region.  These deletions, Dpp6
df1j, Qdpr
df3j, and Dpp6
df4J span the 
region from 23.3 to 29.06 Mb, 40 to 51.9 Mb, and 23.3 to 27.9 Mb, respectively. 
Complementation is shown when there is the presence of at least one mouse that is 
B6*/Deletion.  This means that for every gene that was missing from the deletion 
chromosome there was a normal copy of it within the B6* chromosome.   Thus, if a deletion 
complements with lethal 6, then the mutation can not be within any of the genes that were 
deleted.  All three of these deletions were found to complement lethal 6 (Wilson et al. 2005).  
This result indicates that the lethal 6 gene is not within any of these regions (Figure 2). These 
results had previously narrowed down the possible region to between 28.4 Mb and 40 Mb or 
between 51.9 Mb and 75 Mb. 
 
Figure 2: Possible Gene Region based on complementation tests.  Since lethal 6 
complemented with Dpp6
df1j, Qdpr
df3j, and Dpp6
df4J, the lethal 6 mutation could not be within 
any of these regions, and thus the size was narrowed down to within 29 to 40 Mb or 51.9 to 
75 Mb. 
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  To further narrow down these possible gene regions, I did recombinational mapping. 
B6*/Rw mice were mated with Cast mice, a different strain with a slightly different genome. 
The non-Rw progeny (B6*/Cast) were tail-clipped.  PCR was performed several times for 
each DNA sample using different microsatellite markers spaced around chromosome 5.  
Microsatellites are highly polymorphic DNA elements.  Because the mouse strains are 
slightly different, different alleles from either B6 or Cast have a different number of repeats 
and are therefore different lengths. By PCR amplification and gel electrophoresis the 
different sized alleles can be separated to determine the genotype of the sample.  Since 
B6*/B6* causes embryonic lethality, if a marker is used and the resulting amplicon’s 
genotype is found to be homozygous for B6, then the mutation cannot be within that marker.   
Because the probability of a double crossover is very small, once a B6 homozygote 
was found at a specific marker, the location was narrowed down to be between the 
centromere and the location of that marker.  Eleven B6 homozygotes were found, most 
importantly mouse 3187 (Table 1).  This mouse was found to be homozygous for B6 at 
D5Mit148, which is found at 30.4 Mb, and also homozygous at all markers through 
D5Mit353, at 39 Mb (Figure 3).  This significantly narrowed down the possible region 
between 29.06 and 30.38 Mb, a region consisting of around 1.3 million base pairs (Figure 4). 
 
 
 
 
 
 
 
 
 
 
  7Figure 3: Pictures of Mouse #3187 with markers D5Mit4 and D5Mit148.  A 3% NuSieve 3:1 
Gel was used.  A)  Primer D5Mit4 was used on mouse #3187 (1) and controls B6 (2) and 
Cast (3).  A one-hundred base pair ladder is also shown (4).  B)  Primer D5Mit148 was used 
on mouse #3187 (5) and controls B6 (6) and Cast (7). 
 
      A                           B 
       1           2          3                       4        5         6                  7 
    
 
 
Primer:    D5Mit4      Primer:   D5Mit148 
 
Expected Size of B6:     195      Expected Size of B6:       149    
 
Expected Size of Cast:   238      Expected Size of Cast:     129 
 
Figure 4: Possible Gene Region based on Mapping Data.  Mouse # 3187 was B6*/B6* for all 
markers between the beginning of the Qdpr
df3j (40 Mb) deletion through D5Mit148 (30.4 
Mb).  This narrowed down the possible region to a size of less than 1.4 Mb, from 29.06 Mb 
to 30.38 Mb.   
 
 
  8Table 1: Mapping Data for lethal 6.  Mouse # 3187 was B6*/B6* for all markers from 
D5Mit148, at 30.38 Mb, to D5Mit106, at 43.6 Mb.  This narrowed down the possible region 
to a size of less than 1.4 Mb, from 29.06 Mb to 30.38 Mb.   
 
 
         L5Jcs6  C5Cast intercross        
                      
  Primers  M348 M176 M389  M229  M148 M388 M4 M13 M353 M106 M299 M132 M82 M356 
 
Position 
(Mb) 23  28.4  29.06  30.03  30.38 31.8  34  36  39 43.6  48  52  58 71.8 
  Dpp6<df1J> comp comp                       
  Dpp6<df4J> comp                         
1281 b/c       b/c             b/c  b/c  b/b  
1289 b/c       b/c               b/b  
1548 b/c       b/c         b/b  b/b     b/c   
1555 b/c       b/c           b/c   b/b        b/b  
1948 b/c       b/c       b/c  b/b  b/b  b/b       
1951 b/c       b/c       b/c  b/b  b/b  b/b       
1964 b/c       b/c       b/c  b/c  b/c  b/c       
1980 b/c       b/c       b/c  b/c  b/c  b/b       
3187 b/c       b/c  b/b  b/b  b/b  b/b  b/b  b/b       
5835 b/c          b/c     b/b         
M
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6495 c/c          b / c               
  
 
Finding and Analyzing Candidate Genes: 
 
 
  By using the UCSC and Ensembl Genome Browsers, genes that other researchers had 
found to be expressed and were traced back to the possible lethal 6 gene region were found.  
The genomic positions of these expressed genes are known, but the phenotype remained 
unknown.  In the possible lethal 6 region, thirty-eight genes were found (Figure 5).  Of these 
genes, four had yielded viable progeny when previously mutated: Emilin1, Slc30a3, Ucn, and 
Gckr.  The remaining thirty-four genes were prioritized by their expression patterns and 
known phenotypes.  The expression patterns were determined by researching the Unigene 
database and the known phenotypes from the Jackson Laboratory database.  The Unigene 
database contains expression levels for over thirty tissues and for each developmental stage. 
  9Genes that were ubiquitously expressed in adult tissue or in abundance in early embryonic 
tissue were considered to be more likely than genes that were only present in small amounts 
in adult tissue.  This is because a gene causing embryonic lethality when mutated is expected 
to be an important gene. 
Figure 5:  Candidate Genes within the possible lethal 6 region on Chromosome 5.  These 
genes were found using Ensembl and UCSC Genome Browsers, and are mostly genes that 
are known to be expressed but with unknown function. 
 
 
 
 
  Lethal6/Rw DNA was isolated and used to examine the candidate genes using Wave 
Analysis.  This procedure uses temperature gradient denaturing to separate heterogeneous 
sequences.  It enables us to quickly visualize if the gene is possibly lethal 6.  If the Wave 
Analysis showed that there was possibly a mutation, then the gene was sequenced.  Using 
Wave, sixteen genes were ruled out from being lethal 6: 4930471M23Rik, Cenpa, 
1110039B18Rik, 9430057O19Rik, Khk, Abhd1, 0610007C21Rik, Dnajc5g, Trim54, Gtf3ct, 
Zfp513, Krtcap3, Zfp512, 4930548H24Rik, Mrpl33, and Rbks.  Except for an exon or two, 
fourteen other genes were mostly ruled out: Dpysl5, Mapre3, Slc5a6, Preb, Cad, Snx17, 
  10Ppm1g, Nrbp, Ift172, Fndc4, Xab1, Supt71, Slc4a1ap, and Bre.  This leaves only four genes 
left to analyze: 2310016E02Rik, Tcf23, Mpv17, and Eif2b4, (Figure 6). 
  However, it is possible that the ENU affected a non-coding region.  If so, Wave 
Analysis would not have picked up these mutations because we only compared the coding 
sequences of each candidate gene.  Thus, primers for real time PCR have been designed for 
all 34 possible genes within this region.  RNA will be recovered from lethal 6/Rw mice and 
cDNA will be made by reverse-transcriptase PCR.  Real time PCR will then be done to 
quantify relative gene expression as compared to the control DNA. If there is a considerable 
difference in the amount of lethal 6/Rw product versus control product, it is probable that 
ENU affected the regulatory mechanism of this gene. 
Figure 6:  Genes within the possible lethal 6 region and the combined Wave Analysis and 
Sequencing Results.  
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Determining the time that Lethal 6 Acts: 
 
To determine the time that lethal 6 acts to kill the developing embryo, timed matings 
were done.  Previous results showed that lethal 6 acts in early gestation.  The first timed 
matings that were done were at E9.5 between B6/Rw females and B6/Cast males.  This time 
corresponds with early to mid gestation and halfway through the normal gestation period of 
nineteen to twenty-one days. The pregnant female mice were sacrificed and dissected when 
their progeny were still in utero.  At this time, normal mice should have completed turning 
and become C shaped.  Also, early organogenesis should be underway, as evidenced by the 
presence of the heart and prominent pharyngeal arches.   
Around thirty embryos were genotyped at this stage.  Of these, all looked 
phenotypically normal, and when genotyped, none were B6*/B6* (Figure 7).   
Furthermore, about one quarter of the decidua were empty. The cross should 
theoretically yield one quarter B6*/B6*, one quarter B6*/Cast, one quarter B6*/Rw, and one 
quarter Rw/Cast if all genotypes were equally viable. Since none of the embryos were 
B6*/B6*, and one quarter of the decidua were empty, the mutant lethal 6 embryos died at an 
earlier stage and were reabsorbed. 
Next, twenty-two embryos at E8.5 were analyzed.  Normal embryos at this stage are 
undergoing turning and are between U shaped and linear.  Also, the embryos should have 
their first somites and pharyngeal pouches.  A B6/Rw intercross was done to facilitate 
genotyping.  All twenty-two of the collected embryos were genotypically normal (Figure 8).  
Also, there were seven empty decidua.  This data suggests that lethal 6 acts at an earlier stage 
to kill the mutant embryos. 
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Figure 7:  E9.5 Embryos.  All embryos recovered at this stage looked phenotypically normal 
and were genotypically normal as well. 
 
Genotypes of Embryos:  
 
1 = B6/Cast     2   =   B6/Rw    3   =   Rw/Cast 
 
4 = B6/Rw     5   =   B6/Cast    6   =   Rw/Cast 
 
 
             
         1                   2               3 
 
          
          4             5                6 
 
Blastocyst outgrowths were done to determine if lethal 6 might inhibit the earliest 
stages of embryo growth.  Two mice were sacrificed and a total of twelve embryos were 
flushed out of the uteri.  Of these embryos, seven were able to attach to the growth plate and 
  13five were not.  Of the seven that were able to attach and grow, two were Rw/Rw and five 
were B6*/Rw (Figure 9).  Based on the cross of B6*/Rw with B6*/Rw, one quarter of the 
progeny should be B6*/B6*, one quarter Rw/Rw, and one half B6*/Rw if all were equally 
viable.  This suggests that B6*/B6* is unable to implant in vitro. 
 
Figure 8: E8.5 Embryos.  All embryos at this stage were both phenotypically and 
genotypically normal. 
 
    
 
Genotype: B6/Rw      Genotype:  B6/Rw 
 
Figure 9: Blastocysts.  Of the blastocysts able to implant, none were B6*/B6*. 
 
                                                  
 
  Genotype: B6/Rw      Genotype:    B6/Rw 
  14Discussion: 
 
  Forward genetics is a type of genetic screen that tries to find new genes by 
mutagenizing the genome and finding novel phenotypes.  The mutated genes causing these 
new phenotypes are then isolated and cloned.  In this experiment, lethal 6 was found to be an 
embryonic recessive lethal gene mapping within the Rw region on Chromosome 5.  The 
Lethal 6 mutation was induced with ENU, a point mutagen affecting the male germ line.  It 
was then isolated using a three-generation mutagenesis screen.  This screen yielded no viable 
progeny that were B6*/B6* and thus lethal 6 was acting during embryogenesis. 
  After complementation tests were done to broadly reduce the possible region, PCR 
analysis was done.  Combining the complementation tests and recombinational mapping, the 
possible lethal 6 region was narrowed down to a size of less than 1.4 Mb.  Unfortunately, this 
region is very gene-rich and had thirty-eight genes within it.  Four of these genes were viable 
when knocked-out and were thus ruled out.  Another fifteen genes were ruled out during 
Wave analysis and sequencing.  Yet another thirteen genes were almost all ruled out.  
Currently, six full genes need to be analyzed and it is still possible that ENU affected a 
coding part of these genes.  
  During the mapping process of the entire set of thirty-seven embryonic lethal genes 
that were previously isolated, another five lethal mutations (L5Jcs15, L5Jcs 16, L5Jcs 
24/L5Jcs 27, L5Jcs 31, and L5Jcs 35) were found to map to the same region as lethal 6.  
These mutations have been tested at the same time as lethal 6, thereby increasing the number 
of controls and comparisons used during Wave Analysis.  None of these mutations have been 
found either, although all have been tested with the same genes with which lethal 6 was 
tested.  It is highly unlikely that the six lethal mutations correspond to the remaining six 
  15candidate genes.  Thus, it is probable that ENU affected a regulatory part of these genes and 
not a coding region.  On the other hand, it is also possible that WAVE is not one hundred 
percent efficient and may have missed a mutation.   
  Therefore, the thirty-four genes that lead to unviable progeny when mutated are all 
still possibilities for being lethal 6.  Real-time PCR primers have been made for all thirty-
four of the candidate genes and cDNA has been prepared as well.  If ENU affected a 
regulatory part of one of these genes, then the expression profile of the affected lethal should 
be different than for the control expression data.  By using RT-PCR, the amount of PCR 
product and therefore RNA present can be quantified.  We can see whether a particular lethal 
has a lower amount of RNA expressed for any given gene when compared to the other lethal 
mutations and control cDNA.  If so, then there is a possibility that that lethal corresponds to 
the gene being analyzed.  Future work should concentrate on analyzing the expression 
profiles of these genes with all six lethal gene mutations. 
  Timed matings were done to determine the time that lethal 6 is required to support 
embryonic development.  None of the embryos recovered at E9.5 or E8.5 were B6* 
homozygous and there were several empty decidua in each sacrificed mouse.  The presence 
of empty decidua led us to believe that the mutant embryos had been resorbed at an earlier 
stage.  However, since E8.5 embryos are very delicate and small, it is possible that the 
embryonic tissue was contaminated with maternal tissue.  This would lead to inaccurate 
results when genotyping the embryo.  More embryos at this stage of development need to be 
genotyped to verify the accuracy of the results.  If more embryos are genotyped and there are 
still no B6*/B6* embryos recovered, then it is more likely that our results were accurate. 
  16  Currently, only twelve blastocysts were flushed out of the uterine horns.  Of these, 
only seven were able to implant but none of these were B6*/B6*.  It is possible that B6*/B6* 
embryos are unable to implant, but more outgrowths must be performed to confirm these 
preliminary findings. 
  Overall, while a lot of progress has been made towards identifying and characterizing 
lethal 6, more research must be done.  The remaining exons of the thirteen unfinished genes 
and the full six genes that have not been done still need to be analyzed via Wave to either 
find the lethal 6 mutation or to rule them out.  Also, RT-PCR must be done for all thirty-four 
of these genes to determine if ENU affected a regulatory part of the genes instead of a coding 
part.  It is likely that ENU did affect a non-coding region of one of these genes and hopefully 
real-time PCR will help distinguish the expression profiles.  It is also possible that the lethal 
6 gene is not annotated. 
Also, more blastocysts must be assayed and the ones able to implant must be 
genotyped.  In regards to determining the phenotype, more embryos must be genotyped at 
E8.5 and E7.5 to find out when exactly the embryo succumbs to the lethal 6 mutation.  The 
pattern of expression must be elucidated as well.  Which tissues lethal 6 affects is currently 
unknown.   
If a greater number of blastocyst outgrowths are done and B6*/B6* embryos fail to 
implant, then it is possible that the gene is required for cell growth or implantation.  
However, if it is found that B6*/B6* embryos are able to implant, RNA in situ hybridization 
should be done using Brachyury/T as a marker.  Brachyury T is a mesodermal marker, and is 
first expressed in the primitive streak of the embryo and later in the notochord (Herrmann, 
1991).  A probe will be made that hybridizes to the Brachyury T mRNA.  Only cells 
  17transcribing the Brachyury T gene will have this mRNA, and these cells will be the only ones 
to hybridize with the labeled probe.  Therefore, the labeled probe should only be seen in cells 
of the primitive streak and notochord.  The primitive streak begins developing around E7.0, 
and the late primitive streak is seen at E7.5.  If lethal 6 is disrupting the mesoderm and these 
regions, then the B6*/B6* mutant embryos will have different spatial patterns of expression 
when compared to normal embryos.  These patterns of expression will be helpful in 
determining both when and where lethal 6 acts. 
  18Methods: 
 
ENU Mutagenesis:   
This was done previously (Wilson et al. 2005). 
 
Complementation Tests:  
This was done previously (Wilson et al. 2005). 
 
Recombinational Mapping:  
B6*/Rw mice were mated to Cast/Cast mice and then the non-Rw progeny were intercrossed, 
allowing for recombination between the B6* and Cast chromosomes.  The tails of the F2 
generation were clipped and the DNA was purified.  The DNA was amplified using a number 
of primers spanning the Rw region: D5Mit348, D5Mit387, D5Mit229, D5Mit75, D5Mit353, 
D5Mit231, D5Mit299, D5Mit132, D5Mit82, D5Mit290, and D5Mit356.  These markers are 
all polymorphic between B6 and Cast.  The PCR product was then separated on a 3% 3:1 
NuSieve gel.   
 
Wave Analysis:   
DNA from all 6 lethals was purified and then amplified using the protocol Wave-HD.  The 
PCR products were then checked on a 2% NuSieve gel run at 120 mV. The amount of 
product to inject into the Wave Machine was determined through comparison with the six 
hundred base pair band of the one hundred base pair ladder.  The injection volume ranged 
from 5 µl to 15µl.   
 
Sequencing: 
All sequencing samples were sent to Cornell University’s Biotechnology Resource Center 
and analyzed using Sequencher. 
 
 
  19Outgrowths: 
 
Done according to the established protocol in Manipulating the Mouse Embryo: A 
Laboratory Manual by Nagy et al, 2003.  Blastocysts were grown in 24-well plates with ES 
cell media. 
 
Timed Matings: 
 
B6*/Rw mice were put into the same cage for mating.  Plugs were checked for daily, and 
when a plug was found, this was considered day E0.5.  Mice were sacrificed in the morning 
to get the most accurate age of embryos.  Dissections were done according to the established 
protocol in Manipulating the Mouse Embryo: A Laboratory Manual by Nagy et al, 2003. 
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